Editas Medicine (EDIT) Institutional Ownership

$2.70 -0.02 (-0.74%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$2.75 +0.05 (+1.85%)

As of 09/18/2026 07:50 PM Eastern

Compare

Current Institutional Ownership Percentage: 71.90%
Number of Institutional Buyers (last 12 months): 62
Total Institutional Inflows (last 12 months): $106.16M

Number of Institutional Sellers (last 12 months): 31
Total Institutional Outflows (last 12 months): $15.17M

Get EDIT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Editas Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EDIT Institutional Buying and Selling by Quarter

Editas Medicine Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/9/2026	Opaleye Management Inc.	3,861,930	$12.51M	1.1%	+100.4%	2.515%
8/27/2026	Corient Private Wealth LP	24,646	$80K	0.0%	N/A	0.016%
8/22/2026	Seven Fleet Capital Management LP	1,330,500	$4.31M	0.7%	N/A	0.866%
8/21/2026	AXQ Capital LP	36,452	$118K	0.0%	N/A	0.024%
8/20/2026	Two Sigma Securities LLC	33,138	$107K	0.0%	+216.8%	0.022%
8/19/2026	Hsbc Holdings PLC	97,062	$314K	0.0%	-13.5%	0.063%
8/19/2026	Wellington Management Group LLP	309,395	$1.00M	0.0%	N/A	0.201%
8/19/2026	Nantahala Capital Management LLC	852,700	$2.76M	0.0%	N/A	0.555%
8/17/2026	Seven Fleet Capital Management LP	1,330,500	$4.31M	0.0%	N/A	0.866%
8/17/2026	Corient Private Wealth LP	22,174	$72K	0.0%	N/A	0.014%
Get the Latest News and Ratings for EDIT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter.
8/17/2026	Bank of America Corp DE	231,827	$751K	0.0%	N/A	0.151%
8/14/2026	ADAR1 Capital Management LLC	8,889,000	$28.80M	1.3%	N/A	5.788%
8/14/2026	Hsbc Holdings PLC	97,062	$314K	0.0%	N/A	0.063%
8/14/2026	Canada Pension Plan Investment Board	42,400	$137K	0.0%	N/A	0.028%
8/14/2026	Legal & General Group Plc	9,708	$31K	0.0%	N/A	0.006%
8/14/2026	The Manufacturers Life Insurance Company	27,265	$88K	0.0%	N/A	0.018%
8/12/2026	Ieq Capital LLC	217,785	$706K	0.0%	N/A	0.222%
8/12/2026	Callan Family Office LLC	14,463	$47K	0.0%	N/A	0.015%
8/11/2026	Green Alpha Advisors LLC	156,046	$506K	0.3%	N/A	0.159%
8/11/2026	Vise Technologies Inc.	25,794	$84K	0.0%	N/A	0.026%
8/11/2026	Strategic Advisory Partners LLC	15,028	$49K	0.0%	N/A	0.015%
8/7/2026	BlackRock Inc.	10,589,990	$34.31M	0.0%	N/A	10.816%
8/7/2026	Pallas Capital Advisors LLC	11,711	$38K	0.0%	N/A	0.012%
8/7/2026	Deutsche Bank AG	99,365	$322K	0.0%	N/A	0.101%
8/6/2026	SCS Capital Management LLC	35,000	$113K	0.0%	N/A	0.036%
8/6/2026	Bank of New York Mellon Corp	262,625	$851K	0.0%	N/A	0.268%
8/6/2026	State of Wyoming	21,540	$70K	0.0%	N/A	0.022%
8/6/2026	GSA Capital Partners LLP	367,147	$1.19M	0.1%	N/A	0.375%
8/3/2026	Walleye Capital LLC	183,859	$596K	0.0%	N/A	0.188%
5/20/2026	Arete Wealth Advisors LLC	35,764	$88K	0.0%	N/A	0.037%
5/19/2026	Bank of America Corp DE	134,866	$333K	0.0%	-30.4%	0.138%
5/19/2026	Arete Wealth Advisors LLC	35,764	$88K	0.0%	N/A	0.037%
5/14/2026	Renaissance Technologies LLC	3,972,160	$9.81M	0.0%	+30.7%	4.057%
5/14/2026	Sei Investments Co.	88,707	$219K	0.0%	+19.6%	0.091%
5/14/2026	State of Wyoming	17,380	$43K	0.0%	N/A	0.018%
5/6/2026	Independent Financial Group LLC	20,360	$50K	0.0%	N/A	0.021%
5/5/2026	Bank of New York Mellon Corp	272,567	$673K	0.0%	+11.1%	0.278%
4/28/2026	Abel Hall LLC	14,443	$36K	0.0%	N/A	0.015%
4/16/2026	SG Americas Securities LLC	13,136	$32K	0.0%	-21.8%	0.013%
3/20/2026	Hsbc Holdings PLC	112,186	$231K	0.0%	+17.0%	0.115%
The trade I’ve been waiting for since 2011 (Ad) Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this supercycle - and says that may be conservative. Billionaire Pierre Lassonde has argued for $19,000. Former CIA advisor Jim Rickards targets $27,000 based on a federal revaluation of the gold supply. But the bigger opportunity may not be gold itself. A 'backdoor' gold-linked asset has historically multiplied gold's move by 10x or more - returning 846%, 1,668%, 1,847%, and 1,915% in the last supercycle. Watch the free video briefing and learn the No. 1 trade to leverage rising gold
2/23/2026	Virtu Financial LLC	43,228	$89K	0.0%	N/A	0.044%
2/18/2026	XTX Topco Ltd	246,606	$506K	0.0%	-5.2%	0.253%
2/18/2026	Susquehanna Portfolio Strategies LLC	244,355	$501K	0.0%	-20.7%	0.250%
2/18/2026	Quadrature Capital Ltd	107,376	$220K	0.0%	N/A	0.110%
2/18/2026	Millennium Management LLC	162,330	$333K	0.0%	-51.7%	0.166%
2/18/2026	Man Group plc	79,170	$162K	0.0%	+58.8%	0.081%
2/18/2026	Eversept Partners LP	290,919	$596K	0.0%	N/A	0.298%
2/17/2026	AQR Capital Management LLC	644,197	$1.32M	0.0%	-6.3%	0.660%
2/17/2026	Price T Rowe Associates Inc. MD	92,397	$190K	0.0%	+7.2%	0.095%
2/17/2026	Russell Investments Group Ltd.	95,506	$196K	0.0%	+21.6%	0.098%
2/17/2026	Royal Bank of Canada	12,231	$25K	0.0%	-96.6%	0.013%
2/17/2026	Graham Capital Management L.P.	139,904	$287K	0.0%	+108.6%	0.143%
2/16/2026	Squarepoint Ops LLC	91,846	$188K	0.0%	+48.0%	0.094%
2/16/2026	MML Investors Services LLC	37,855	$78K	0.0%	-22.9%	0.039%
2/16/2026	Mariner LLC	41,321	$85K	0.0%	-46.6%	0.042%
2/16/2026	Barclays PLC	276,262	$566K	0.0%	+47.7%	0.283%
2/13/2026	Stifel Financial Corp	44,843	$92K	0.0%	-92.3%	0.046%
2/13/2026	Jacobs Levy Equity Management Inc.	827,140	$1.70M	0.0%	+3.4%	0.847%
2/13/2026	Charles Schwab Investment Management Inc.	794,671	$1.63M	0.0%	+1.9%	0.814%
2/13/2026	Police & Firemen s Retirement System of New Jersey	16,844	$35K	0.0%	-39.8%	0.017%
2/13/2026	State Street Corp	1,974,931	$4.05M	0.0%	+2.6%	2.023%
2/13/2026	Ieq Capital LLC	89,193	$183K	0.0%	-40.8%	0.091%
2/13/2026	Wells Fargo & Company MN	162,744	$334K	0.0%	+26.8%	0.167%
2/12/2026	MetLife Investment Management LLC	17,022	$35K	0.0%	-55.8%	0.017%
2/12/2026	StoneX Group Inc.	15,855	$33K	0.0%	N/A	0.016%
2/12/2026	Renaissance Technologies LLC	3,039,778	$6.23M	0.0%	+138.0%	3.114%
2/12/2026	Dimensional Fund Advisors LP	335,479	$688K	0.0%	-64.0%	0.344%
2/12/2026	EntryPoint Capital LLC	84,554	$173K	0.1%	N/A	0.087%
2/12/2026	Nuveen LLC	1,976,900	$4.05M	0.0%	-5.5%	2.025%
2/11/2026	LPL Financial LLC	64,856	$133K	0.0%	+56.6%	0.066%
2/11/2026	Los Angeles Capital Management LLC	97,803	$200K	0.0%	-16.9%	0.100%
2/10/2026	Goldman Sachs Group Inc.	881,960	$1.81M	0.0%	+92.5%	0.903%
2/9/2026	Geode Capital Management LLC	2,284,740	$4.69M	0.0%	+12.0%	2.340%
2/6/2026	GSA Capital Partners LLP	568,809	$1.17M	0.1%	N/A	0.583%
1/30/2026	R Squared Ltd	14,365	$29K	0.0%	-30.4%	0.015%
1/14/2026	Hennion & Walsh Asset Management Inc.	279,534	$573K	0.0%	+15.7%	0.286%
1/14/2026	DLK Investment Management LLC	16,619	$34K	0.0%	-43.3%	0.017%
1/7/2026	Green Alpha Advisors LLC	161,120	$330K	0.3%	+10.0%	0.165%
1/1/2026	JPMorgan Chase & Co.	820,667	$2.85M	0.0%	-23.0%	0.841%
11/21/2025	CIBC Bancorp USA Inc.	16,296	$57K	0.0%	N/A	0.017%
11/17/2025	Jacobs Levy Equity Management Inc.	800,023	$2.78M	0.0%	+761.7%	0.820%
11/17/2025	CANADA LIFE ASSURANCE Co	45,754	$161K	0.0%	+43.3%	0.047%
11/17/2025	XTX Topco Ltd	260,113	$903K	0.0%	+95.7%	0.266%
11/17/2025	Public Employees Retirement System of Ohio	75,500	$262K	0.0%	N/A	0.077%
11/17/2025	Mariner LLC	77,415	$269K	0.0%	+44.1%	0.079%
11/17/2025	Millennium Management LLC	335,788	$1.17M	0.0%	-82.1%	0.344%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	40,328	$140K	0.0%	-14.9%	0.041%
11/17/2025	Bank of America Corp DE	1,024,240	$3.55M	0.0%	-5.1%	1.049%
11/17/2025	Alliancebernstein L.P.	167,530	$581K	0.0%	-8.8%	0.172%
11/17/2025	Ameriprise Financial Inc.	188,144	$653K	0.0%	N/A	0.193%
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes
11/14/2025	Raymond James Financial Inc.	163,888	$569K	0.0%	-10.0%	0.168%
11/14/2025	Man Group plc	49,844	$173K	0.0%	N/A	0.051%
11/14/2025	Two Sigma Investments LP	1,584,155	$5.50M	0.0%	+63.3%	1.623%
11/14/2025	Bridgeway Capital Management LLC	76,000	$264K	0.0%	-36.7%	0.078%
11/14/2025	Squarepoint Ops LLC	62,073	$215K	0.0%	N/A	0.064%
11/13/2025	Sei Investments Co.	13,312	$46K	0.0%	N/A	0.014%
11/13/2025	UBS Group AG	422,394	$1.47M	0.0%	-33.0%	0.433%
11/13/2025	BNP Paribas Financial Markets	27,168	$94K	0.0%	+33.3%	0.028%
11/13/2025	Russell Investments Group Ltd.	78,568	$273K	0.0%	+1,635.9%	0.080%
11/13/2025	Dynamic Technology Lab Private Ltd	72,840	$253K	0.0%	N/A	0.075%

EDIT Institutional Ownership - Frequently Asked Questions

During the previous two years, 134 institutional investors and hedge funds held shares of Editas Medicine. The most heavily invested institutionals were BlackRock Inc. ($34.31M), ADAR1 Capital Management LLC ($28.80M), Vanguard Group Inc. ($24.17M), Opaleye Management Inc. ($12.51M), Renaissance Technologies LLC ($9.81M), Two Sigma Investments LP ($5.50M), and Geode Capital Management LLC ($4.69M).Learn more on Editas Medicine's institutional investors.

71.90% of Editas Medicine's stock is owned by institutional investors. Learn more on EDIT's institutional investor holdings.

Of the 109 institutional investors that purchased Editas Medicine's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($10.59M), ADAR1 Capital Management LLC ($8.89M), Renaissance Technologies LLC ($4.15M), Seven Fleet Capital Management LP ($2.66M), Opaleye Management Inc. ($1.93M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($1.70M), and Jacobs Levy Equity Management Inc. ($1.22M).

Institutional investors have bought a total of 34,347,957 shares in the last 24 months. This purchase volume represents approximately $106.16M in transactions.

Of the 31 institutional investors that sold Editas Medicine's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.71M), Dimensional Fund Advisors LP ($1.07M), Stifel Financial Corp ($535.44K), JPMorgan Chase & Co. ($490.11K), Royal Bank of Canada ($345.99K), UBS Group AG ($207.97K), and Vanguard Group Inc. ($193.87K).

Institutional investors have sold a total of 5,238,191 shares in the last 24 months. This volume of shares sold represents approximately $15.17M in transactions.

Related Companies

Institutional ownership data for NASDAQ:EDIT is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Editas Medicine (EDIT) Institutional Ownership

EDIT Institutional Buying and Selling by Quarter

Editas Medicine Major Shareholders & Ownership History

EDIT Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Editas Medicine (EDIT) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Editas Medicine (NASDAQ:EDIT)

EDIT Institutional Buying and Selling by Quarter

Editas Medicine Major Shareholders & Ownership History

EDIT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of EDIT shares?

What percentage of Editas Medicine's stock is owned by institutional investors?

Which institutional investors have been buying Editas Medicine's stock?

How much institutional buying is happening at Editas Medicine?

Which of Editas Medicine's major shareholders have been selling company stock?

How much institutional selling is happening at Editas Medicine?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools